2024-511410-20-01RecruitingPhase 1
A Study to Learn How Different Manufactured Products of the Study Medicine Called Osivelotor (PF-07940367) Taste and Are Taken Up Into the Blood When Mixed With Soft Foods or Liquids Given on an Empty Stomach or Given With Food or an Acid Reducing Agent in Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 7 Sept 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- First submitted
- 4 Aug 2026
- Start date
- 14 Sept 2026
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-511410-20-01
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 52
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy adults. It studies how different forms of the study medicine osivelotor (PF-07940367) taste and are taken up into the blood.
- Age
- 18 years or older
- Sex
- All sexes can join.
This trial only enrols healthy participants. The registry sentence this rests on: A Study to Learn How Different Manufactured Products of the Study Medicine Called Osivelotor (PF-07940367) Taste and Are Taken Up Into the Blood When Mixed With Soft Foods or Liquids Given on an Empty Stomach or Given With Food or an Acid Reducing Agent in Healthy Adults
Read by machine on 9 Nov 2026.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit | Brussels | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.